SCHEMBL8287979

SCHEMBL8287979

Cc1cc2c(c(Oc3ccccn3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.37
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
GSK3B P49841 3/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KCNH2 Q12809 1/20 0.33
CYP1A2 P05177 1/20 0.32
AHR P35869 1/20 0.32
MAT2A P31153 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
CCND2 P30279 1/20 0.32
CCND3 P30281 1/20 0.32
P2RX7 Q99572 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287983 0.87 PDE11A (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8287488 0.85 PDE11A (0.36) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286424 0.84 MAT2A (0.41) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286426 0.84 PDE11A (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286141 0.82 PDE11A (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286457 0.81 LMNA (0.38) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286140 0.81 PDE11A (0.37) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8287534 0.81 PDE11A (0.34) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL8286076 0.80 PDE11A (0.39) PDE11AGAAHPGDMAPK1GSK3B
SCHEMBL5872270 0.80 PDE11A (0.44) PDE11AGAAHPGDMAPK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed